Indian pharma firms oppose bid to extend drug exclusivity period to 10 years
Indian drugmakers are raising concerns over a commerce ministry proposal to extend the country's new-drug validity period from four to 10 years, the Economic Times reports. Indian drugmakers are raising concerns over...To view the full article, register now.
Already a subscriber? Click here to view full article